Media stories about Agilent Technologies (NYSE:A) have been trending somewhat positive on Monday, Accern Sentiment Analysis reports. Accern scores the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Agilent Technologies earned a news sentiment score of 0.24 on Accern’s scale. Accern also gave media stories about the medical research company an impact score of 45.8767636203772 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Here are some of the media stories that may have effected Accern Sentiment’s analysis:
- Agilent (A) Down 2.6% Since Earnings Report: Can It Rebound? (finance.yahoo.com)
- This Morning’s Technical Outlook on Medical Research Stocks — Agilent Technologies, BioTelemetry, Accelerate Diagnostics, and Biocept (bizjournals.com)
- $1.21 Billion in Sales Expected for Agilent Technologies Inc (A) This Quarter (americanbankingnews.com)
- Agilent Introduces New Color for Cancer Diagnosis (finance.yahoo.com)
- Sr Vice President of Agilent Technologies Inc (NYSE:A), Kaltenbach Patrick, sells 6,875 shares worth $490,738 (empowerednews.net)
Shares of Agilent Technologies stock traded down $0.56 during mid-day trading on Monday, hitting $69.34. 2,639,402 shares of the stock traded hands, compared to its average volume of 2,501,455. The company has a quick ratio of 2.78, a current ratio of 3.23 and a debt-to-equity ratio of 0.40. Agilent Technologies has a twelve month low of $52.26 and a twelve month high of $75.00. The company has a market capitalization of $22,557.94, a PE ratio of 117.53, a price-to-earnings-growth ratio of 2.33 and a beta of 1.30.
A number of equities analysts have weighed in on A shares. ValuEngine cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Deutsche Bank set a $75.00 price objective on shares of Agilent Technologies and gave the company a “buy” rating in a research report on Tuesday, November 21st. Barclays upped their price objective on shares of Agilent Technologies from $67.00 to $71.00 and gave the company an “overweight” rating in a research report on Tuesday, November 21st. JPMorgan Chase & Co. upped their price objective on shares of Agilent Technologies from $75.00 to $80.00 and gave the company an “overweight” rating in a research report on Thursday, February 15th. Finally, Evercore ISI started coverage on shares of Agilent Technologies in a research report on Wednesday, January 3rd. They issued an “outperform” rating and a $75.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $71.27.
In related news, CEO Michael R. Mcmullen sold 21,850 shares of the stock in a transaction dated Monday, January 29th. The shares were sold at an average price of $75.00, for a total transaction of $1,638,750.00. Following the sale, the chief executive officer now owns 324,687 shares in the company, valued at $24,351,525. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Michael R. Mcmullen sold 43,703 shares of the stock in a transaction dated Friday, January 5th. The stock was sold at an average price of $70.00, for a total transaction of $3,059,210.00. Following the sale, the chief executive officer now owns 302,837 shares in the company, valued at approximately $21,198,590. The disclosure for this sale can be found here. In the last quarter, insiders have sold 101,103 shares of company stock worth $7,258,967.
ILLEGAL ACTIVITY NOTICE: This report was first reported by BBNS and is the property of of BBNS. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://baseballnewssource.com/2018/03/20/agilent-technologies-a-receiving-somewhat-favorable-news-coverage-analysis-finds/2020377.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.